Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

NCT01694264 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

43

Enrollment

OTHER

Sponsor class

Stopped Delayed recruitment, unable to meet calculated sample size

Conditions

Chronic Hepatitis B
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Juvenile Idiopathic Arthritis

Interventions

DRUG: Entecavir
DRUG: Placebo

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]